Merck & Co (MRK)

Add to Watchlists
Create an Alert
61.28 +0.25  +0.41% NYSE Jun 20, 20:00 Delayed 2m USD

Merck & Co Research and Development Expense (Quarterly):

3.196B for March 31, 2018
View 4,000+ financial data types
View Full Chart

Merck & Co Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Merck & Co Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2018 3.196B
Dec. 31, 2017 2.281B
Sept. 30, 2017 4.383B
June 30, 2017 1.749B
March 31, 2017 1.83B
Dec. 31, 2016 4.649B
Sept. 30, 2016 1.664B
June 30, 2016 2.151B
March 31, 2016 1.659B
Dec. 31, 2015 1.798B
Sept. 30, 2015 1.50B
June 30, 2015 1.67B
March 31, 2015 1.737B
Dec. 31, 2014 2.283B
Sept. 30, 2014 1.659B
June 30, 2014 1.664B
March 31, 2014 1.574B
Dec. 31, 2013 1.835B
Sept. 30, 2013 1.66B
June 30, 2013 2.101B
March 31, 2013 1.907B
Dec. 31, 2012 2.224B
Sept. 30, 2012 1.918B
June 30, 2012 2.165B
March 31, 2012 1.862B
Dec. 31, 2011 2.419B
Sept. 30, 2011 1.954B
June 30, 2011 1.936B
March 31, 2011 2.158B
Dec. 31, 2010 4.559B
Sept. 30, 2010 2.322B
June 30, 2010 2.179B
March 31, 2010 2.051B
Dec. 31, 2009 1.972B
Sept. 30, 2009 1.254B
June 30, 2009 1.395B
March 31, 2009 1.224B
Dec. 31, 2008 1.386B
Sept. 30, 2008 1.171B
June 30, 2008 1.169B
March 31, 2008 1.078B
Dec. 31, 2007 1.382B
Sept. 30, 2007 1.440B
June 30, 2007 1.030B
March 31, 2007 1.03B
Dec. 31, 2006 1.723B
Sept. 30, 2006 945.40M
June 30, 2006 1.172B
March 31, 2006 942.00M
Dec. 31, 2005 1.112B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


MRK Research and Development Expense (Quarterly) Benchmarks

Bristol-Myers Squibb 1.25B
Celgene 2.203B
Johnson & Johnson 2.404B

MRK Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 1.50B Sep 2015
Maximum 4.649B Dec 2016
Average 2.152B

MRK Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("MRK", "r_and_d_expense")
  • Last 5 data points: =YCS("MRK", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.